News and events from NCI-funded research and programs
Adding the drug to standard hormone therapy helped men with metastatic disease live longer.
Benefit seen even in patients previously treated with other HER2-targeted drugs.
At a molecular level, tumors in blacks and whites are more similar than different.
Recent Press Releases